資料請求はこちら ▶


慢性腎臓病(CKD) 【新着】

  • 168 Renal hemodynamics across the adult lifespan: Relevance of flow pulsatility to chronic kidney disease. Exp Gerontol.2021
    doi: 10.1016/j.exger.2021.111459. PubMed
  • 166 Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study. BMC Nephrol.2021
    doi: 10.1186/s12882-021-02398-8. PubMed
  • 165 Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease. Can J Vet Res.2021
  • 慢性腎臓病(CKD)関連文献の一覧へ ▶

    急性腎障害(AKI) 【新着】

    • 173Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio isrelated to worsening renal function in patients undergoing elective percutaneous coronary intervention. Clin Exp Nephrol. 2021
      doi: 10.1007/s10157-021-02113-9.PubMed
    • 172First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19. Open Forum Infect Dis. 2021
      doi: 10.1093/ofid/ofab274.PubMed
    • 171COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine. Clin Exp Nephrol. 2021
      doi: 10.1007/s10157-021-02101-z.PubMed
    • 170Assessment of Cardiopulmonary Bypass Duration Improves Novel Biomarker Detection for Predicting Postoperative Acute Kidney Injury after Cardiovascular Surgery. J Clin Med. 2021
      doi: 10.3390/jcm10132741.PubMed
    • 169Urinary liver-type fatty acid-binding protein variation as a predictive value of short-term mortality in intensive care unit patients. Ren Fail. 2021
      doi: 10.1080/0886022X.2021.1943439.PubMed

    急性腎障害(AKI)関連文献の一覧へ ▶

    薬剤性腎障害(Toxicology) 【新着】

    • 167Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study. AIDS Res Ther.2021
      doi: 10.1186/s12981-021-00354-y.PubMed
    • 153 Early changes in tubular dysfunction markers and phosphorus metabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleoside analog therapy for chronic hepatitis B patients. Hepatol Res.2020
      doi: 10.1111/hepr.13451. PubMed
    • 145The influence of renal function by ibuprofen treatment for patent ductus arteriosus in extremely low-birth-weight infants.Pediatr Int.2019PubMed

    薬剤性腎障害(Toxicology)関連文献の一覧へ ▶

    薬理学(Pharmacology) 【新着】

    • 138Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study.Diabetol Int.2018PubMed
    • 136Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.Naunyn Schmiedebergs Arch Pharmacol.2018PubMed
    • 129Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucoselowering-independent manner.BMJ Open Diabetes Res Care.2017PubMed

    薬理学(Pharmacology)関連文献の一覧へ ▶

    運動(Exercise) 【新着】

    • 148 Effects of exercise on residual renal function in patients undergoing peritoneal dialysis: a post-hoc analysis of a randomized controlled trial. Ther Apher Dial.2020PubMed
    • 139Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice.Hypertens Res.2019PubMed
    • 124Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults.Clin Exp Hypertens.2017PubMed

    運動(Exercise)関連文献の一覧へ ▶

    日本語総説 【新着】

    • J46 慢性腎臓病の重症化予防に向けた運動の役割 体力科学誌2019
    • J45 習慣的な運動による老化関連疾患の予防医学のあゆみ2018
    • J44 SGLT2 阻害薬ルセオグリフロジンの腎機能障害合併2 型糖尿病患者に対する有用性の検討 診療と新薬55, 2018

    日本語総説の一覧へ ▶


    一覧へ ▶


    資料請求はこちら ▶



尿中L-FABP をサンドイッチ法で比色定量するELISAキットです。対象動物:ラット、イヌ、ネコ、サル、ブタ。



レナプロ® L-FABPテスト

TOPへ ▲
TOPページへ ▶